US 5,688,944 A · Carbamazepine derivatives

Abstract

The present invention provides a novel carbamazepine hydrazide compound suitable for covalent attachment to a polymer particle reagent, having the general formula ##STR1## The present invention also provides a novel carbamazepine acid compound suitable for attachment to proteins for the production of carbamazepine immunogens. The carbamazepine antigen of the present invention has the following general structure: ##STR2## where X is C.dbd.O, CH.sub.2 or SO.sub.2 ; Y is C.dbd.O, CH.sub.2, SO.sub.2 ; R is an alkyl and P is a protein or a hapten.

Claims1

Dependent claims

A compound having the structural formula ##STR12##

Dependencies are inferred from the claim text.

Facts

Application

08/473,810Filed 7 Jun 1995

Granted

18 Nov 1997

Term ends

Not estimatedThe source records don’t support an estimate.

Classification15 codes

G01N 33/532
Production of immunochemical test materials: production of labelled immunochemicals
C07D 223/22
Dibenzazepines; Hydrogenated dibenzazepines: dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
C07D 223/32
Condensed with carbocyclic rings or ring systems: containing carbocyclic rings other than six-membered
G01N 33/9473
Involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors: anticonvulsants, e.g. phenobarbitol, phenytoin

Carbamazepine derivatives

Life of this patent

Abstract

Claims1

Carbamazepine derivatives

Life of this patent

Abstract

Claims1